BIOHAVEN LTD (BHVN) Stock Analyst Ratings
USA - NYSE:BHVN - VGG1110E1079 - Common Stock
14.85 USD
-2.35 (-13.66%)
14.86 USD
+0.01 (+0.07%)
ChartMill assigns a Buy % Consensus number of 88% to BHVN. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 47.24. This target is 218.11% above the current price.
BHVN was analyzed by 24 analysts. The buy percentage consensus is at 88. So analysts seem to be very confident about BHVN.
In the previous month the buy percentage consensus was at a similar level.
BHVN was analyzed by 24 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-09-17 | Citigroup | Initiate | Buy |
| 2025-09-16 | UBS | Maintains | Buy -> Buy |
| 2025-09-03 | Raymond James | Initiate | Strong Buy |
| 2025-08-19 | BTIG | Maintains | Buy -> Buy |
| 2025-08-12 | Leerink Partners | Maintains | Outperform -> Outperform |
| 2025-08-12 | Baird | Maintains | Outperform -> Outperform |
| 2025-08-12 | B of A Securities | Maintains | Buy -> Buy |
| 2025-08-12 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-08-12 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-06-18 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-05-19 | RBC Capital | Downgrade | Outperform -> Sector Perform |
| 2025-05-13 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-04-28 | Baird | Maintains | Outperform -> Outperform |
| 2025-03-07 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-03-05 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-03-04 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2025-03-04 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-02-11 | Deutsche Bank | Initiate | Buy |
| 2024-12-17 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-12-17 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-12-04 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-11-26 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-25 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-11-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-13 | TD Cowen | Maintains | Buy -> Buy |
| 2024-11-13 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-10-23 | Cantor Fitzgerald | Reiterate | Overweight |
| 2024-10-04 | Cantor Fitzgerald | Reiterate | Overweight |
| 2024-10-03 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-09-24 | Cantor Fitzgerald | Reiterate | Overweight |
BIOHAVEN LTD / BHVN FAQ
Can you provide the average price target for BIOHAVEN LTD stock?
24 analysts have analysed BHVN and the average price target is 47.24 USD. This implies a price increase of 218.11% is expected in the next year compared to the current price of 14.85.
What is the consensus rating for BHVN stock?
The consensus rating for BIOHAVEN LTD (BHVN) is 87.5 / 100 . This indicates that analysts generally have a positive outlook on the stock.
What is the number of analysts for BHVN stock?
The number of analysts covering BIOHAVEN LTD (BHVN) is 24.